Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K B Huh

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Yonsei Medical Journal|March 1, 1993
Peak bone mass and affecting factors in Korean womenS K Lim, N H Lee, J H Lee, et al.
Clinical Endocrinology|March 1, 1994
Pulsatile gonadotrophin-releasing hormone therapy in patients with pituitary tumours treated by surgery and irradiationK H Park, W I Park, B S Lee, et al.
Diabetes & Metabolism|November 6, 2019
Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetesD H Seo, Y-H Lee, S W Park, et al.
The Korean Journal of Internal Medicine|July 1, 1986
Human leukocyte antigen (HLA) in Korean patients with autoimmune thyroid diseasesK B Huh, H C Lee, H M Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Absence of constitutively activating mutations in the GHRH receptor in GH-producing pituitary tumorsE J Lee, T J Kotlar, I Ciric, et al.
Metabolism: Clinical and Experimental|November 1, 1995
Acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid levels in hyperthyroidismE J Lee, K R Kim, H C Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1997
Altered hydroxylation of estrogen in patients with postmenopausal osteopeniaS K Lim, Y J Won, J H Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1995
Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjectsE J Lee, S Y Nam, K R Kim, et al.
Diabetes Research and Clinical Practice|February 14, 2002
(AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitusH K Park, C W Ahn, G T Lee, et al.
Journal of Diabetes and Its Complications|April 15, 2000
Effects of long-acting somatostatin analogue (Sandostatin) on manifest diabetic ketoacidosisY S Yun, H C Lee, C S Park, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Yonsei Medical Journal|March 1, 1993
Peak bone mass and affecting factors in Korean womenS K Lim, N H Lee, J H Lee, et al.
Clinical Endocrinology|March 1, 1994
Pulsatile gonadotrophin-releasing hormone therapy in patients with pituitary tumours treated by surgery and irradiationK H Park, W I Park, B S Lee, et al.
Diabetes & Metabolism|November 6, 2019
Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetesD H Seo, Y-H Lee, S W Park, et al.
The Korean Journal of Internal Medicine|July 1, 1986
Human leukocyte antigen (HLA) in Korean patients with autoimmune thyroid diseasesK B Huh, H C Lee, H M Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Absence of constitutively activating mutations in the GHRH receptor in GH-producing pituitary tumorsE J Lee, T J Kotlar, I Ciric, et al.
Metabolism: Clinical and Experimental|November 1, 1995
Acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid levels in hyperthyroidismE J Lee, K R Kim, H C Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1997
Altered hydroxylation of estrogen in patients with postmenopausal osteopeniaS K Lim, Y J Won, J H Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1995
Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjectsE J Lee, S Y Nam, K R Kim, et al.
Diabetes Research and Clinical Practice|February 14, 2002
(AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitusH K Park, C W Ahn, G T Lee, et al.
Journal of Diabetes and Its Complications|April 15, 2000
Effects of long-acting somatostatin analogue (Sandostatin) on manifest diabetic ketoacidosisY S Yun, H C Lee, C S Park, et al.
Pageof 7